Affiliation:
1. Orel State University n.a. I.S. Turgenev
Abstract
The pandemic of a new coronavirus infection in recent years has led to more frequent and aggressive prescription of antibiotic therapy, which could not but affect the intestinal microbiota. In addition, the direct effect of coronavirus on enterocytes leads to the development of subclinical inflammation in the intestinal wall, contributing to the disruption of the qualitative and quantitative composition of the normal intestinal microflora. Against this background, the number of patients with antibiotic-associated diarrhea, including diarrhea caused by C. difficile, including severe ones. Moreover, the number of clostridial diarrhea resistant to classical vancomycin therapy has increased, which dictates the need to find new ways to treat patients and methods for further prevention of such conditions.
Subject
Materials Chemistry,Economics and Econometrics,Media Technology,Forestry
Reference8 articles.
1. Granata G., Bartoloni A., Codeluppi M., Contadini I. et al. The Burden of Clostridioides Difficile Infection during the COVID-19 Pandemic: A Retrospective Case-Control Study in Italian Hospitals (CloVid). J Clin Med. 2020. No. 9. E3855. DOI: 10.3390/jcm9123855.
2. Garrigues E., Janvier P., Kherabi Y., Le Bot A. et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020. No. 81 (6). P. 4–6. DOI: 10.1016/j.jinf.2020.08.029.
3. Timofeeva A.A., Shul'pekova Yu.O., Nechaev V.M., Skhirtladze M. R. Infektsiya Slostridium difficile u patsientki s COVID-19. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2021. № 31 (3). S. 68–73. DOI: 10.22416/1382–4376–2021–31–3–68–73. Timofeeva A. A., Shulpekova Yu.O., Nechaev V. M., Shirtladze M.R. Clostridium difficile infection in a patient with COVID-19. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021. No. 31 (3). P. 68–73. DOI: 10.22416/1382–4376–2021–31–3–68–73.
4. Ivashkin V.T., Yushchuk N.D., Maev I.V., Lapina T.L. i dr. Rekomendatsii Rossiiskoi gastroenterologicheskoi assotsiatsii po diagnostike i lecheniyu Clostridium difficileassotsiirovannoi bolezni. Rossiiskii zhurnal gastroenterologii gepatologii, koloproktologii. 2016. № 26 (5). S. 56–65. Ivashkin V. T., Yuschuk N. D., Maev I. V., Lapina T. L. i dr. Recommendations of the Russian Gastroenterological Association for the diagnosis and treatment of Clostridium difficile-associated disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016. No. 26 (5). P. 56–65.
5. Shelygin Yu. A., Aleshkin V. A., Sukhina M. A. i dr. Klinicheskie rekomendatsii Natsional'noi assotsiatsii spetsialistov po kontrolyu infektsii, svyazannykh s okazaniem meditsinskoi pomoshchi, i Obshcherossiiskoi obshchestvennoi nekommercheskoi organizatsii «Assotsiatsiya koloproktologov Rossii» po diagnostike, lecheniyu i profilaktike Clostridium difficile-assotsiirovannoi diarei (CDI). Koloproktologiya. 2018. № 3 (65). S. 7–23. DOI: 10.33878/2073–7556–2018–0–3–7–23. Sheligin Yu.A., Aleshkin V. A., Suhina M. A. et al. Clinical guidelines of the National Association of Infection Control Specialists associated with the provision of medical care and the All-Russian public non-profit organization ‘Association of Coloproctologists of Russia on the diagnosis, treatment and prevention of Clostridium difficile-associated diarrhea (CDI)’. Coloproctology. 2018. No. 3 (65). P. 7–23. DOI: 10.33878/2073–7556–2018–0–3–7–23.